Atomoxetine: Treatment of attention-deficit/hyperactivity disorder through selective norepinephrine reuptake inhibition

Christopher J. Kratochvil, Martin J. Harrington, William J. Burke, Brigette S. Vaughan

Research output: Contribution to journalReview article

Fingerprint Dive into the research topics of 'Atomoxetine: Treatment of attention-deficit/hyperactivity disorder through selective norepinephrine reuptake inhibition'. Together they form a unique fingerprint.

Medicine & Life Sciences